Cancer Treatment Drugs Market Report

Global and Region Cancer Treatment Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：157
  • REPORT CODE：GMM1014301
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Cancer Treatment Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Treatment Drugsmarket, defines the market attractiveness level of Cancer Treatment Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Cancer Treatment Drugs industry, describes the types of Cancer Treatment Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Treatment Drugs market and the development prospects and opportunities of Cancer Treatment Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Treatment Drugs market in Chapter 13.

    By Player:

    • Sanofi

    • Bayer

    • Johnson & Johnson

    • Amgen

    • AbbVie

    • Biogen Idec

    • Merck & Co

    • Roche

    • Eli Lilly

    • Ipsen

    • Teva

    • Pfizer

    • Merck KGaA

    • Eisai

    • Celgene

    • Takeda

    • Gilead Sciences

    • Otsuka

    • Novartis

    • Astellas

    • Bristol-Myers Squibb

    • AstraZeneca

    By Type:

    • Chemotherapy

    • Targeted Therapy

    • Immunotherapy

    • Hormonal Therapy (Biologic Therapy)

    • Others

    By End-User:

    • Blood Cancer

    • Breast Cancer

    • Gastrointestinal Cancer

    • Prostate Cancer

    • Respiratory/Lung Cancer

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Cancer Treatment Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Cancer Treatment Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Cancer Treatment Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Cancer Treatment Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Cancer Treatment Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Cancer Treatment Drugs Consumption (2017-2022)

    • 7.2 United States Cancer Treatment Drugs Consumption (2017-2022)

    • 7.3 Europe Cancer Treatment Drugs Consumption (2017-2022)

    • 7.4 China Cancer Treatment Drugs Consumption (2017-2022)

    • 7.5 Japan Cancer Treatment Drugs Consumption (2017-2022)

    • 7.6 India Cancer Treatment Drugs Consumption (2017-2022)

    • 7.7 South Korea Cancer Treatment Drugs Consumption (2017-2022)

    8 Region and Country-wise Cancer Treatment Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Cancer Treatment Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Cancer Treatment Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Cancer Treatment Drugs Consumption Forecast (2022-2028)

    • 8.4 China Cancer Treatment Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Cancer Treatment Drugs Consumption Forecast (2022-2028)

    • 8.6 India Cancer Treatment Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Cancer Treatment Drugs Consumption Forecast (2022-2028)

    9 Global Cancer Treatment Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Cancer Treatment Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Targeted Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Immunotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Hormonal Therapy (Biologic Therapy) Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Cancer Treatment Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Blood Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Respiratory/Lung Cancer Consumption and Growth Rate (2017-2022)

    10 Global Cancer Treatment Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Cancer Treatment Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Hormonal Therapy (Biologic Therapy) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Cancer Treatment Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Respiratory/Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    11 Global Cancer Treatment Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Cancer Treatment Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Cancer Treatment Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Cancer Treatment Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Cancer Treatment Drugs Market Competitive Analysis

    • 14.1 Sanofi

      • 14.1.1 Sanofi Company Details

      • 14.1.2 Sanofi Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Sanofi Cancer Treatment Drugs Product and Service

    • 14.2 Bayer

      • 14.2.1 Bayer Company Details

      • 14.2.2 Bayer Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bayer Cancer Treatment Drugs Product and Service

    • 14.3 Johnson & Johnson

      • 14.3.1 Johnson & Johnson Company Details

      • 14.3.2 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Johnson & Johnson Cancer Treatment Drugs Product and Service

    • 14.4 Amgen

      • 14.4.1 Amgen Company Details

      • 14.4.2 Amgen Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Amgen Cancer Treatment Drugs Product and Service

    • 14.5 AbbVie

      • 14.5.1 AbbVie Company Details

      • 14.5.2 AbbVie Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 AbbVie Cancer Treatment Drugs Product and Service

    • 14.6 Biogen Idec

      • 14.6.1 Biogen Idec Company Details

      • 14.6.2 Biogen Idec Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Biogen Idec Cancer Treatment Drugs Product and Service

    • 14.7 Merck & Co

      • 14.7.1 Merck & Co Company Details

      • 14.7.2 Merck & Co Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Merck & Co Cancer Treatment Drugs Product and Service

    • 14.8 Roche

      • 14.8.1 Roche Company Details

      • 14.8.2 Roche Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Roche Cancer Treatment Drugs Product and Service

    • 14.9 Eli Lilly

      • 14.9.1 Eli Lilly Company Details

      • 14.9.2 Eli Lilly Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Eli Lilly Cancer Treatment Drugs Product and Service

    • 14.10 Ipsen

      • 14.10.1 Ipsen Company Details

      • 14.10.2 Ipsen Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Ipsen Cancer Treatment Drugs Product and Service

    • 14.11 Teva

      • 14.11.1 Teva Company Details

      • 14.11.2 Teva Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Teva Cancer Treatment Drugs Product and Service

    • 14.12 Pfizer

      • 14.12.1 Pfizer Company Details

      • 14.12.2 Pfizer Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Pfizer Cancer Treatment Drugs Product and Service

    • 14.13 Merck KGaA

      • 14.13.1 Merck KGaA Company Details

      • 14.13.2 Merck KGaA Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Merck KGaA Cancer Treatment Drugs Product and Service

    • 14.14 Eisai

      • 14.14.1 Eisai Company Details

      • 14.14.2 Eisai Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Eisai Cancer Treatment Drugs Product and Service

    • 14.15 Celgene

      • 14.15.1 Celgene Company Details

      • 14.15.2 Celgene Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Celgene Cancer Treatment Drugs Product and Service

    • 14.16 Takeda

      • 14.16.1 Takeda Company Details

      • 14.16.2 Takeda Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Takeda Cancer Treatment Drugs Product and Service

    • 14.17 Gilead Sciences

      • 14.17.1 Gilead Sciences Company Details

      • 14.17.2 Gilead Sciences Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Gilead Sciences Cancer Treatment Drugs Product and Service

    • 14.18 Otsuka

      • 14.18.1 Otsuka Company Details

      • 14.18.2 Otsuka Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Otsuka Cancer Treatment Drugs Product and Service

    • 14.19 Novartis

      • 14.19.1 Novartis Company Details

      • 14.19.2 Novartis Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Novartis Cancer Treatment Drugs Product and Service

    • 14.20 Astellas

      • 14.20.1 Astellas Company Details

      • 14.20.2 Astellas Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Astellas Cancer Treatment Drugs Product and Service

    • 14.21 Bristol-Myers Squibb

      • 14.21.1 Bristol-Myers Squibb Company Details

      • 14.21.2 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Bristol-Myers Squibb Cancer Treatment Drugs Product and Service

    • 14.22 AstraZeneca

      • 14.22.1 AstraZeneca Company Details

      • 14.22.2 AstraZeneca Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 AstraZeneca Cancer Treatment Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Cancer Treatment Drugs

    • Figure Cancer Treatment Drugs Picture

    • Table Global Cancer Treatment Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Treatment Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Treatment Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Cancer Treatment Drugs Consumption by Country (2017-2022)

    • Figure United States Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Treatment Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Hormonal Therapy (Biologic Therapy) Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Respiratory/Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormonal Therapy (Biologic Therapy) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Respiratory/Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Cancer Treatment Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Cancer Treatment Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Cancer Treatment Drugs Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Cancer Treatment Drugs Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Cancer Treatment Drugs Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Cancer Treatment Drugs Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Cancer Treatment Drugs Product and Service

    • Table Biogen Idec (Foundation Year, Company Profile and etc.)

    • Table Biogen Idec Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Idec Cancer Treatment Drugs Product and Service

    • Table Merck & Co (Foundation Year, Company Profile and etc.)

    • Table Merck & Co Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Cancer Treatment Drugs Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Cancer Treatment Drugs Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Cancer Treatment Drugs Product and Service

    • Table Ipsen (Foundation Year, Company Profile and etc.)

    • Table Ipsen Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ipsen Cancer Treatment Drugs Product and Service

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Cancer Treatment Drugs Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Cancer Treatment Drugs Product and Service

    • Table Merck KGaA (Foundation Year, Company Profile and etc.)

    • Table Merck KGaA Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck KGaA Cancer Treatment Drugs Product and Service

    • Table Eisai (Foundation Year, Company Profile and etc.)

    • Table Eisai Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Cancer Treatment Drugs Product and Service

    • Table Celgene (Foundation Year, Company Profile and etc.)

    • Table Celgene Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Cancer Treatment Drugs Product and Service

    • Table Takeda (Foundation Year, Company Profile and etc.)

    • Table Takeda Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Cancer Treatment Drugs Product and Service

    • Table Gilead Sciences (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Cancer Treatment Drugs Product and Service

    • Table Otsuka (Foundation Year, Company Profile and etc.)

    • Table Otsuka Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Otsuka Cancer Treatment Drugs Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Cancer Treatment Drugs Product and Service

    • Table Astellas (Foundation Year, Company Profile and etc.)

    • Table Astellas Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Cancer Treatment Drugs Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Cancer Treatment Drugs Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Cancer Treatment Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US